Suchergebnisse - (Person:"Sheng, Jifang")

PubPharm (15)

1

A randomized, controlled, multicenter clinical trial to evaluate the efficacy and safety of oral sitafloxacin versus moxifloxacin in adult patients with community-acquired pneumonia

enthalten in: Current medical research and opinion | 2021

von Li, Y. | Zhu, D. | Peng, Y. | +25

2

Combining Hepatitis B Virus RNA and Hepatitis B Core-Related Antigen : Guidance for Safely Stopping Nucleos(t)ide Analogues in Hepatitis B e Antigen-Positive Patients With Chronic Hepatitis B

enthalten in: The Journal of infectious diseases | 2020

von Fan, R. | Peng, J. | Xie, Q. | +25

3

Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2020

von Fan, R. | Zhou, B. | Xu, M. | +27

CommentIn: Clin Gastroenterol Hepatol. 2020 Mar;18(3):551-552. - PMID 31473358

4

Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2020

von Hou, J. | Zhao, W. | Lee, C. | +34

CommentIn: Clin Gastroenterol Hepatol. 2020 Aug;18(9):2146-2147. - PMID 32088301

5

Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B : 5-year results

enthalten in: Hepatology international | 2019

von Liang, X. | Gao, Z. | Xie, Q. | +23

6

Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b : a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China

enthalten in: BMC gastroenterology | 2019

von Sun, J. | Ding, H. | Chen, G. | +21

7

A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis

enthalten in: Medicine | 2016

von Ma, H. | Zeng, M. | Han, Y. | +24

8

HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients

enthalten in: Virology journal | 2016

von Yang, S. | Xing, H. | Wang, Y. | +27

9

Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues

enthalten in: Gut | 2016

von Fan, R. | Sun, J. | Yuan, Q. | +29

10

Randomized, three-arm study to optimize lamivudine efficacy in hepatitis B e antigen-positive chronic hepatitis B patients

enthalten in: Journal of gastroenterology and hepatology | 2015

von Liang, X. | Cheng, J. | Sun, Y. | +26